These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28709798)

  • 21. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Khanal A; Budhathoki N; Singh VP; Shah BK
    Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
    Jiang S; Jiang H; Sun L; Luo Z
    Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
    Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
    Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
    J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
    Ganti A; Plitt MA; Kuan EC; Kuhar HN; Batra PS; Tajudeen BA
    Int Forum Allergy Rhinol; 2018 Jun; 8(6):756-762. PubMed ID: 29381260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC).
    Wu X; Zhang X; Tao L; Chen P
    BMC Cancer; 2020 Aug; 20(1):719. PubMed ID: 32746796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period.
    Lee KD; Chen CY; Huang HJ; Wang TY; Teng D; Huang SH; Lai CH; Chen MC
    BMC Cancer; 2015 May; 15():393. PubMed ID: 25957789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second Primary Malignancies of the Bones and Joints: More Common than Expected in Osteosarcoma Patients.
    Freedman IG; Dowd HN; Dhodapkar MM; Halperin SJ; Grauer JN
    J Am Acad Orthop Surg Glob Res Rev; 2023 Jan; 7(1):. PubMed ID: 36695170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
    Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC
    Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.